Meeder Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-269	Closed	-$3.38K	–	1020
2024 Q4	$3.38K	Buy	+269	New	+$4.05K	﹤0.01%	869
2024 Q3	–	Sell	-178	Closed	-$3.83K	–	934
2024 Q2	$3.83K	Buy	+178	New	+$4.09K	﹤0.01%	805
2021 Q4	–	Sell	-4,221	Closed	-$127K	–	2068
2021 Q3	$127K	Buy	4,221 +3,453	+450%	+$126K	0.01%	839
2021 Q2	$34K	Buy	768 +83	+12%	+$3.6K	﹤0.01%	1270
2021 Q1	$30K	Buy	+685	New	+$37.6K	﹤0.01%	1284
2020 Q4	–	Sell	-556	Closed	-$12K	–	2154
2020 Q3	$12K	Buy	+556	New	+$13.7K	﹤0.01%	1322
2020 Q2	–	Sell	-147	Closed	-$2K	–	2387
2020 Q1	$2K	Buy	147 +52	+55%	+$1.03K	﹤0.01%	2112
2019 Q4	$2K	Sell	95 -7,426	-99%	-$124K	﹤0.01%	2046
2019 Q3	$88K	Buy	+7,521	New	+$93.3K	0.01%	846
2018 Q1	–	Sell	-394	Closed	-$4K	–	1715
2017 Q4	$4K	Sell	394 -372	-49%	-$3.69K	﹤0.01%	1377
2017 Q3	$5K	Buy	766 +608	+385%	+$2.78K	﹤0.01%	1274
2017 Q2	$1K	Hold	158	–	–	﹤0.01%	1543
2017 Q1	$1K	Sell	158 -42	-21%	-$282	﹤0.01%	1544
2016 Q4	$5K	Buy	+200	New	+$5.71K	﹤0.01%	859